当前位置:首页 - 行情中心 - 仁和药业(000650) - 财务分析 - 现金流量表

仁和药业

(000650)

  

流通市值:82.01亿  总市值:86.24亿
流通股本:13.31亿   总股本:14.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,239,324,883.79853,461,972.414,682,139,870.223,375,617,481.06
  收到的税费返还9,566.879,566.872,025,309.36735,444.84
  收到其他与经营活动有关的现金113,614,112.3487,512,304213,237,385.42174,707,570.53
  经营活动现金流入小计2,352,948,563940,983,843.284,897,402,5653,551,060,496.43
  购买商品、接受劳务支付的现金1,085,631,515.73512,284,293.122,771,624,901.232,030,294,583.64
  支付给职工以及为职工支付的现金274,687,525.18167,012,084.93543,830,545.49425,955,030.41
  支付的各项税费174,511,732.4768,244,310.79644,810,225.12485,453,550.15
  支付其他与经营活动有关的现金146,677,896.1675,157,819.88379,878,809.72310,993,390.53
  经营活动现金流出小计1,681,508,669.54822,698,508.724,340,144,481.563,252,696,554.73
  经营活动产生的现金流量净额671,439,893.46118,285,334.56557,258,083.44298,363,941.7
二、投资活动产生的现金流量:
  收回投资收到的现金4,600,560,979.112,197,800,8849,568,514,696.444,923,113,104.06
  取得投资收益收到的现金40,140,512.1425,860,447.9482,632,775.735,846,674.54
  处置固定资产、无形资产和其他长期资产收回的现金净额32,234.7918,4808,949,585.718,567,410.58
  投资活动现金流入小计4,640,733,726.042,223,679,811.949,660,097,057.854,967,527,189.18
  购建固定资产、无形资产和其他长期资产支付的现金42,411,635.4932,207,015.13285,717,962.97237,642,827.06
  投资支付的现金6,451,769,798.854,120,629,086.139,836,817,599.986,902,006,003.61
  取得子公司及其他营业单位支付的现金23,169.71---
  投资活动现金流出小计6,494,204,604.054,152,836,101.2610,122,535,562.957,139,648,830.67
  投资活动产生的现金流量净额-1,853,470,878.01-1,929,156,289.32-462,438,505.1-2,172,121,641.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金80,000-2,640,0002,300,000
  其中:子公司吸收少数股东投资收到的现金80,000-2,640,0002,300,000
  收到其他与筹资活动有关的现金0-70,060,00070,060,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计80,000-72,700,00072,360,000
  分配股利、利润或偿付利息支付的现金211,818,640.332,160,774.19410,662,551.42307,449,339.08
  其中:子公司支付给少数股东的股利、利润2,160,774.192,160,774.19130,731,378.0727,840,196.04
  支付其他与筹资活动有关的现金0045,821,237.339,930,992.3
  筹资活动现金流出小计211,818,640.332,160,774.19456,483,788.72347,380,331.38
  筹资活动产生的现金流量净额-211,738,640.33-2,160,774.19-383,783,788.72-275,020,331.38
五、现金及现金等价物净增加额-1,393,769,624.88-1,813,031,728.95-288,964,210.38-2,148,778,031.17
  加:期初现金及现金等价物余额2,325,564,672.742,325,564,672.742,614,528,883.122,614,528,883.12
  期末现金及现金等价物余额931,795,047.86512,532,943.792,325,564,672.74465,750,851.95
补充资料:
  净利润355,240,856.89-566,585,713.01-
  资产减值准备-99,651.05-113,319,610.32-
  固定资产和投资性房地产折旧49,866,986.19-92,577,772.52-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧49,866,986.19-92,577,772.52-
  无形资产摊销7,251,544.98-24,028,495.66-
  长期待摊费用摊销1,811,477.82-2,840,724.84-
  处置固定资产、无形资产和其他长期资产的损失-2,000,511.4--1,365,132.54-
  固定资产报废损失149,572.46-63,736.29-
  公允价值变动损失-39,303.94--16,033,837.69-
  财务费用43,293.13-166,965.55-
  投资损失-26,729,093.05--72,701,938.99-
  递延所得税2,389,711.5--6,164,484.39-
  其中:递延所得税资产减少2,419,071.41--4,394,232.98-
    递延所得税负债增加-29,359.91--1,770,251.41-
  存货的减少121,785,151.43-7,713,384.28-
  经营性应收项目的减少-19,579,650.04-149,680,170.77-
  经营性应付项目的增加164,308,462.55--353,640,485.9-
  其他8,134,270.8-15,529,062.5-
  现金的期末余额931,795,047.86-2,325,564,672.74-
  减:现金的期初余额2,325,564,672.74-2,614,528,883.12-
  现金及现金等价物的净增加额-1,393,769,624.88--288,964,210.38-
公告日期2025-08-262025-04-292025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑